Table Graph
      published meta-analysis   sensitivity analysis   studies

control in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias viral clearance detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 0.86 [0.46; 1.61] 0.86[0.46; 1.61]Q-PROTECT (HCQ/AZI vs PLACEBO), 202010%299NAnot evaluable viral clearance by day 14detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 0.55 [0.32; 0.94] 0.55[0.32; 0.94]Q-PROTECT (HCQ/AZI vs PLACEBO), 202010%292NAnot evaluable viral clearance by day 7detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 0.86 [0.46; 1.61] 0.86[0.46; 1.61]Q-PROTECT (HCQ/AZI vs PLACEBO), 202010%299NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-11 20:49 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 649,650,589,651,968 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons